Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference35 articles.
1. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial;Eschbach;Ann Intern Med,1989
2. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients;Bohlius;J Natl Cancer Inst,2006
3. Hematocrit level and associated mortality in hemodialysis patients;Ma;J Am Soc Nephrol,1999
4. Hematocrit levels and hospitalization risks in hemodialysis patients;Xia;J Am Soc Nephrol,1999
5. Correction of anemia with epoetin alfa in chronic kidney disease;Singh;N Engl J Med,2006
Cited by 451 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hypoxia‐inducible factor prolyl hydroxylase domain inhibitors may mitigate loss of skeletal muscle mass in haemodialysis patients;JCSM Rapid Communications;2024-01-04
2. The Influence of Precursor Depletion and dose Regimens on Resistance to Erythropoiesis-Stimulating Agents: Insights from Simulations with Instantaneous Dose-Adaptation Algorithm;Journal of Pharmaceutical Sciences;2024-01
3. Cardiovascular safety of current and emerging drugs to treat anaemia in chronic kidney disease: a safety review;Expert Opinion on Drug Safety;2023-12-02
4. Contemporary Practice of Anemia Treatment Among Dialysis Patients in the United States;Kidney International Reports;2023-12
5. Hyporesponsiveness to Erythropoietin-Stimulating Agents: Possible Solutions;Updates on Hemodialysis;2023-09-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3